Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: updated results of a multicentric trial.
Boccardo F, Barichello M, Battaglia M, Carmignani G, Comeri G, Ferraris V, Lilliu S, Montefiore F, Portoghese F, Cortellini P, Rigatti P, Usai E, Rubagotti A; Italian Prostate Cancer Group. Boccardo F, et al. Among authors: rubagotti a. Eur Urol. 2002 Nov;42(5):481-90. doi: 10.1016/s0302-2838(02)00435-9. Eur Urol. 2002. PMID: 12429158 Clinical Trial.
Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer.
Boccardo F, Amadori D, Guglielmini P, Sismondi P, Farris A, Agostara B, Gambi A, Catalano G, Faedi M, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Oncology. 2010;78(3-4):274-81. doi: 10.1159/000315735. Epub 2010 Jun 8. Oncology. 2010. PMID: 20530973 Clinical Trial.
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.
Boccardo F, Rubagotti A, Barichello M, Battaglia M, Carmignani G, Comeri G, Conti G, Cruciani G, Dammino S, Delliponti U, Ditonno P, Ferraris V, Lilliu S, Montefiore F, Portoghese F, Spano G. Boccardo F, et al. Among authors: rubagotti a. J Clin Oncol. 1999 Jul;17(7):2027-38. doi: 10.1200/JCO.1999.17.7.2027. J Clin Oncol. 1999. PMID: 10561254 Clinical Trial.
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.
Boccardo F, Rubagotti A, Battaglia M, Di Tonno P, Selvaggi FP, Conti G, Comeri G, Bertaccini A, Martorana G, Galassi P, Zattoni F, Macchiarella A, Siragusa A, Muscas G, Durand F, Potenzoni D, Manganelli A, Ferraris V, Montefiore F. Boccardo F, et al. Among authors: rubagotti a. J Clin Oncol. 2005 Feb 1;23(4):808-15. doi: 10.1200/JCO.2005.12.013. J Clin Oncol. 2005. PMID: 15681525 Clinical Trial.
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
Boccardo F, Rubagotti A, Conti G, Potenzoni D, Manganelli A, Del Monaco D. Boccardo F, et al. Among authors: rubagotti a. Cancer Chemother Pharmacol. 2005 Oct;56(4):415-20. doi: 10.1007/s00280-005-1016-1. Epub 2005 Apr 19. Cancer Chemother Pharmacol. 2005. PMID: 15838655 Clinical Trial.
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
Boccardo F, Rubagotti A, Puntoni M, Guglielmini P, Amoroso D, Fini A, Paladini G, Mesiti M, Romeo D, Rinaldini M, Scali S, Porpiglia M, Benedetto C, Restuccia N, Buzzi F, Franchi R, Massidda B, Distante V, Amadori D, Sismondi P. Boccardo F, et al. Among authors: rubagotti a. J Clin Oncol. 2005 Aug 1;23(22):5138-47. doi: 10.1200/JCO.2005.04.120. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009955 Clinical Trial.
Switching to aromatase inhibitors in early breast cancer.
Boccardo F, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Lancet. 2007 Feb 17;369(9561):533-5. doi: 10.1016/S0140-6736(07)60201-3. Lancet. 2007. PMID: 17307082 No abstract available.
121 results